MEDIATION OF THE ANTIDEPRESSANT-LIKE EFFECT OF 8-OH-DPAT IN MICE BY POSTSYNAPTIC 5-HT1A RECEPTORS

被引:80
作者
LUSCOMBE, GP
MARTIN, KF
HUTCHINS, LJ
GOSDEN, J
HEAL, DJ
机构
[1] Boots Pharmaceuticals Research Department, Nottingham
关键词
8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN (8-OH-DPAT); ANTIDEPRESSANT; 5-HT1A RECEPTORS; PORSOLT TEST;
D O I
10.1111/j.1476-5381.1993.tb12859.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The 5-hydroxytryptamine (5-HT)1A agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) has been evaluated in a mouse model for detecting potential antidepressants (Porsolt test). The effects of various receptor antagonists, lesions of brain monoaminergic neurones and chronic drug treatments on this 8-OH-DPAT-induced response have also been determined. 2 8-OH-DPAT (0.3-10.0 mg kg-1, s.c.) dose-dependently increased the mobility of mice in the Porsolt test. Other selective 5-HT1A receptor ligands (0.3-30 mg kg-1, s.c.) either mimicked the 8-OH-DPAT response (ipsapirone, at 10 and 30 mg kg-1, s.c.) or were inactive (buspirone and gepirone). However, each of these compounds (less-than-or-equal-to 100 mg kg-1, p.o.) inhibited the response to 8-OH-DPAT (3 mg kg-1, s.c.) when given concurrently. 3 The putative 5-HT1A antagonists, spiroxatrine (1-30 mg kg-1, p.o.), (+/-)-pindolol (30 mg kg-1, p.o.) and methiothepin (3- 10 mg kg-1, p.o.), each attenuated the 8-OH-DPAT (3 mg kg-1, s.c.)-induced increase in mobility. 4 The dopamine D1 receptor antagonist, SCH 23390 (3-10 mg kg-1, p.o.), weakly reversed the 8-OH-DPAT response. Antagonists at 5-HT1C/5-HT2 receptors (ketanserin; 0.1-3.0 mg kg-1, p.o.), 5-HT3 receptors (ondansetron; 0.03-10 mg kg-1, p.o.), alpha1-adrenoceptors (prazosin, 1-3 mg kg-1, p.o.), alpha2-adrenoceptors (idazoxan; 3-30 mg kg-1, p.o.), beta1-adrenoceptors (metoprolol; 1-30 mg kg-1, p.o.), beta2-adrenoceptors (ICI 118,551; 1-30 mg kg-1, p.o.), dopamine D2 receptors (sulpiride; 10-300 mg kg-1, p.o.) and opiate receptors (naloxone; 3-100 mg kg-1, p. o.) had no effect on the 8-OH-DPAT response. 5 Selective destruction of 5-HT neurones with 5,7-dihydroxytryptamine or inhibition of 5-HT synthesis with p-chlorophenylalanine did not change the 8-OH-DPAT response in the Porsolt test. This response was also unaltered by pretreatment with the noradrenergic neurotoxin, DSP-4. 6 Administration of 8-OH-DPAT (3 mg kg-1, s.c.) twice-daily for 10 days attenuated the hypothermia, but not the increased mobility, induced by 8-OH-DPAT (3 mg kg-1, s.c.). Similarly, repeated administration of amitriptyline (3-30 mg kg-1), desipramine (3-30 mg kg-1) or dothiepin (10-100 mg kg-1) also attenuated the former, but not the latter, response. 7 We conclude that 8-OH-DPAT produces an antidepressant-like effect in the Porsolt test which is mediated via postsynaptic 5-HT1A receptors.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 58 条
[1]  
ABLAD B, 1975, ACTA PHARMACOL TOX, V36, P7
[2]  
BENEKE M, 1988, PSYCHOPHARMACOL S, V96, pS353
[3]   THE PHARMACOLOGY OF A BETA-2-SELECTIVE ADRENOCEPTOR ANTAGONIST (ICI-118,551) [J].
BILSKI, AJ ;
HALLIDAY, SE ;
FITZ GERALD, JD ;
WALE, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) :430-437
[4]  
BUCKETT WR, 1982, BRIT J PHARMACOL, V75, pP170
[5]   POTENTIAL ANTIDEPRESSANT PROPERTIES OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN-1A RECEPTOR AGONIST [J].
CERVO, L ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 144 (02) :223-229
[6]   8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, A SELECTIVE SEROTONIN1A RECEPTOR AGONIST, REDUCES THE IMMOBILITY OF RATS IN THE FORCED SWIMMING TEST BY ACTING ON THE NUCLEUS RAPHE DORSALIS [J].
CERVO, L ;
GRIGNASCHI, G ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 158 (1-2) :53-59
[7]   INVOLVEMENT OF 5-HT1A RECEPTORS IN THE ANTIDEPRESSANT-LIKE ACTIVITY OF GEPIRONE IN THE FORCED SWIMMING TEST IN RATS [J].
CHOJNACKAWOJCIK, E ;
TATARCZYNSKA, E ;
GOLEMBIOWSKA, K ;
PRZEGALINSKI, E .
NEUROPHARMACOLOGY, 1991, 30 (07) :711-717
[8]   DOPAMINE ANTAGONISTIC EFFECTS OF A SERIES OF ANALOGS OF OXIPEROMIDE AND SPIROXATRINE MEASURED BEHAVIORALLY IN RODENT [J].
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (11) :693-698
[9]  
COTT JM, 1988, PSYCHOPHARMACOL BULL, V24, P164
[10]   INVIVO EVIDENCE THAT 5-HYDROXYTRYPTAMINE (5-HT) NEURONAL FIRING AND RELEASE ARE NOT NECESSARILY CORRELATED WITH 5-HT METABOLISM [J].
CRESPI, F ;
GARRATT, JC ;
SLEIGHT, AJ ;
MARSDEN, CA .
NEUROSCIENCE, 1990, 35 (01) :139-144